DUBLIN--(BUSINESS WIRE)--Aug 29, 2018--The "Klebsiella Pneumoniae Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

Klebsiella Pneumoniae Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018' report provides comprehensive insights about marketed and Phase III products for Klebsiella Pneumoniae Infections.

Coverage of API manufacturers for Klebsiella Pneumoniae Infections marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' name along with their location.

This report provides a comprehensive understanding of the emerging Phase III therapies for Klebsiella Pneumoniae Infections which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.

Key Topics Covered:

1. Report Introduction

2. Klebsiella Pneumoniae Infections: Overview

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

5. Emerging Therapies (Phase III)

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/tm9s33/klebsiella?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180829005660/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/29/2018 02:19 PM/DISC: 08/29/2018 02:19 PM

http://www.businesswire.com/news/home/20180829005660/en